» Authors » Alexander T F Bell

Alexander T F Bell

Explore the profile of Alexander T F Bell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 66
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bell A, Mitchell J, Kiemen A, Lyman M, Fujikura K, Lee J, et al.
Cell Syst . 2024 Aug; 15(8):753-769.e5. PMID: 39116880
This study introduces a new imaging, spatial transcriptomics (ST), and single-cell RNA-sequencing integration pipeline to characterize neoplastic cell state transitions during tumorigenesis. We applied a semi-supervised analysis pipeline to examine...
2.
Zhang S, Yuan L, Danilova L, Mo G, Zhu Q, Deshpande A, et al.
Genome Med . 2023 Sep; 15(1):72. PMID: 37723590
Background: Novel immunotherapy combination therapies have improved outcomes for patients with hepatocellular carcinoma (HCC), but responses are limited to a subset of patients. Little is known about the inter- and...
3.
Deshpande A, Loth M, Sidiropoulos D, Zhang S, Yuan L, Bell A, et al.
Cell Syst . 2023 Aug; 14(8):722. PMID: 37591207
No abstract available.
4.
Deshpande A, Loth M, Sidiropoulos D, Zhang S, Yuan L, Bell A, et al.
Cell Syst . 2023 Apr; 14(4):285-301.e4. PMID: 37080163
Recent advances in spatial transcriptomics (STs) enable gene expression measurements from a tissue sample while retaining its spatial context. This technology enables unprecedented in situ resolution of the regulatory pathways...
5.
Zhang S, Yuan L, Danilova L, Mo G, Zhu Q, Deshpande A, et al.
bioRxiv . 2023 Jan; PMID: 36712023
Novel immunotherapy combination therapies have improved outcomes for patients with hepatocellular carcinoma (HCC), but responses are limited to a subset of patients and recurrence can also occur. Little is known...
6.
Cuburu N, Bialkowski L, Pontejo S, Sethi S, Bell A, Kim R, et al.
Proc Natl Acad Sci U S A . 2022 Jun; 119(26):e2116738119. PMID: 35749366
Tumor infiltration by T cells profoundly affects cancer progression and responses to immunotherapy. However, the tumor immunosuppressive microenvironment can impair the induction, trafficking, and local activity of antitumor T cells....